Cisplatin and paclitaxel are associated with improved progression-free survival compared to cisplatin alone during interval debulking surgery with hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian cancer
用户Lz2LyWF0h8HA
1小时前
7
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-04 15:45:31 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

